Market Overview:
The global platelet and plasma market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising demand for blood transfusions, and technological advancements in the field of blood transfusion. Based on type, the global platelet and plasma market is segmented into platelets and plasma. Platelets are further sub-segmented into fresh frozen plasma (FFP) and cryoprecipitate. Plasma is further sub-segmented into albumin, immunoglobulin (IgG), factor VIII (FVIII), erythropoietin (EPO), granulocytes colony stimulating factor (G-CSF), monocytes colony stimulating factor (M-CSF) and others. Based on application, the global platelet and plasma market is segmented into hospitals, clinics, ambulatory surgical centres, research laboratories/institutes/centres; blood banks; others). Geographically, the global platelet &plasma market is segmented into North America,, Latin America,, Europe,, Asia Pacificand Middle East & Africa).
Product Definition:
A platelet is a type of blood cell that helps the body form clots to stop bleeding. Platelets are produced in the bone marrow. A plasma is a straw-colored liquid component of blood that contains proteins, minerals, and other substances necessary for life.
Platelet:
Platelets are a part of the blood cells and they help the body to clot blood. They are also important in wound healing process. The main function of platelets is to stop bleeding by plugging small holes in the skin. When a cut is made in our body, Platelet’s rush towards the site of injury and form a plug which helps to stop bleeding. It also helps re-epithelialization (rebuilding) process after surgery or accident etc.
Plasma:
Plasma is the fourth state of matter after solid, liquid and gas. It has a lower boiling point than water but higher than air. The most common way to create plasma is by heating blood above its boiling point. This process creates gases that contain components such as oxygen, nitrogen and carbon dioxide along with other compounds.
Application Insights:
The global market is segmented by application into hospitals, clinics, ambulatory surgical centers, and others. The clinics segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as increasing awareness about blood disorders and growing aging population with high risk of developing these disorders. In addition, due to rising disposable income among consumers globally, the demand for plateletpheresis products has increased significantly over the past few years.
The hospital segment is expected to witness significant growth during forecast period owing to an increase in number of trauma cases worldwide resulting from wars and political unrest which leads to a rise in number of surgeries being performed at a time as well as an increase in prevalence rate for various blood disorders such as hemophilia and thrombocytopenia which boosts product demand further.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare spending in this region. Moreover, increasing prevalence of cardiovascular disorders and other bleeding disorders is expected to drive growth during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period due to rising disposable income and improving healthcare facilities in emerging countries such as China and India. In addition, an increase in road accidents has led to a rise in demand for plateletpheresis products across Asia Pacific which will further boost revenue generation over the next eight years.
Growth Factors:
- Increasing incidence of chronic diseases: The prevalence of chronic diseases such as cancer, cardiovascular disorders, and diabetes is increasing at an alarming rate across the globe. This is expected to drive the demand for platelet and plasma products in the coming years.
- Growing awareness about blood donation: There is a growing awareness among people about blood donation and its benefits. This is likely to boost the demand for platelet and plasma products in the near future.
- Technological advancements in blood transfusion therapies: The technological advancements in blood transfusion therapies are helping to improve patient outcomes significantly. This is propelling the growth of the global platelet and plasma market considerably.
Scope Of The Report
Report Attributes
Report Details
Report Title
Platelet and Plasma Market Research Report
By Type
Platelet, Plasma
By Application
Hosptials, Clinics, Ambulatory Surgical Centres, Others
By Companies
America’s Blood Centers, American Red Cross, American Association of Blood Banks, Blood Centers of America, Brazilian Red Cross, Canadian Red Cross, European Blood Alliance, French Red Cross, German Red Cross, Indian Red Cross, Italian Red Cross, Red Cross Society of China, Saudi Red Crescent Authority, South African Red Cross Society
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
188
Number of Tables & Figures
132
Customization Available
Yes, the report can be customized as per your need.
Global Platelet and Plasma Market Report Segments:
The global Platelet and Plasma market is segmented on the basis of:
Types
Platelet, Plasma
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hosptials, Clinics, Ambulatory Surgical Centres, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- America’s Blood Centers
- American Red Cross
- American Association of Blood Banks
- Blood Centers of America
- Brazilian Red Cross
- Canadian Red Cross
- European Blood Alliance
- French Red Cross
- German Red Cross
- Indian Red Cross
- Italian Red Cross
- Red Cross Society of China
- Saudi Red Crescent Authority
- South African Red Cross Society
Highlights of The Platelet and Plasma Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Platelet
- Plasma
- By Application:
- Hosptials
- Clinics
- Ambulatory Surgical Centres
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Platelet and Plasma Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Platelets are small blood cells that help to form clots. Plasma is the liquid portion of blood.
Some of the key players operating in the platelet and plasma market are America¢â‚¬â„¢s Blood Centers, American Red Cross, American Association of Blood Banks, Blood Centers of America, Brazilian Red Cross, Canadian Red Cross, European Blood Alliance, French Red Cross, German Red Cross, Indian Red Cross, Italian Red Cross, Red Cross Society of China, Saudi Red Crescent Authority, South African Red Cross Society.
The platelet and plasma market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Platelet and Plasma Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Platelet and Plasma Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Platelet and Plasma Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Platelet and Plasma Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Platelet and Plasma Market Size & Forecast, 2018-2028
4.5.1 Platelet and Plasma Market Size and Y-o-Y Growth
4.5.2 Platelet and Plasma Market Absolute $ Opportunity
Chapter 5 Global Platelet and Plasma Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Platelet and Plasma Market Size Forecast by Type
5.2.1 Platelet
5.2.2 Plasma
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Platelet and Plasma Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Platelet and Plasma Market Size Forecast by Applications
6.2.1 Hosptials
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centres
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Platelet and Plasma Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Platelet and Plasma Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Platelet and Plasma Analysis and Forecast
9.1 Introduction
9.2 North America Platelet and Plasma Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Platelet and Plasma Market Size Forecast by Type
9.6.1 Platelet
9.6.2 Plasma
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Platelet and Plasma Market Size Forecast by Applications
9.10.1 Hosptials
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centres
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Platelet and Plasma Analysis and Forecast
10.1 Introduction
10.2 Europe Platelet and Plasma Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Platelet and Plasma Market Size Forecast by Type
10.6.1 Platelet
10.6.2 Plasma
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Platelet and Plasma Market Size Forecast by Applications
10.10.1 Hosptials
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centres
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Platelet and Plasma Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Platelet and Plasma Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Platelet and Plasma Market Size Forecast by Type
11.6.1 Platelet
11.6.2 Plasma
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Platelet and Plasma Market Size Forecast by Applications
11.10.1 Hosptials
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centres
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Platelet and Plasma Analysis and Forecast
12.1 Introduction
12.2 Latin America Platelet and Plasma Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Platelet and Plasma Market Size Forecast by Type
12.6.1 Platelet
12.6.2 Plasma
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Platelet and Plasma Market Size Forecast by Applications
12.10.1 Hosptials
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centres
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Platelet and Plasma Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Platelet and Plasma Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Platelet and Plasma Market Size Forecast by Type
13.6.1 Platelet
13.6.2 Plasma
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Platelet and Plasma Market Size Forecast by Applications
13.10.1 Hosptials
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centres
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Platelet and Plasma Market: Competitive Dashboard
14.2 Global Platelet and Plasma Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 America’s Blood Centers
14.3.2 American Red Cross
14.3.3 American Association of Blood Banks
14.3.4 Blood Centers of America
14.3.5 Brazilian Red Cross
14.3.6 Canadian Red Cross
14.3.7 European Blood Alliance
14.3.8 French Red Cross
14.3.9 German Red Cross
14.3.10 Indian Red Cross
14.3.11 Italian Red Cross
14.3.12 Red Cross Society of China
14.3.13 Saudi Red Crescent Authority
14.3.14 South African Red Cross Society
